A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Psychedelics biotech company Enveric Biosciences (NASDAQ: ENVB) has presented research highlighting the company's lead ...

Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic ...

KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic diseaseKT-621 ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

PharmaLegacy Laboratories is snapping up BTS Research in hopes of expanding its reach as a preclinical CRO.  | PharmaLegacy ...

AUSTIN, Texas, Sept. 20, 2024 /PRNewswire/ — Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments ...